Company Filing History:
Years Active: 2008
Title: Holger Kirstein: Innovator in Organic Chemistry
Introduction
Holger Kirstein is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of organic chemistry, particularly in the synthesis of valuable intermediate products for pharmaceutical applications. His work has implications for the production of tissue-selective estrogens, which are important in medical treatments.
Latest Patents
Holger Kirstein holds a patent for the "Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens." This invention relates to intermediate products and a new process for the production of benzocycloheptene C. The process begins with economical starting materials and provides intermediate stages in high yields and high purity, without the need for chromatographic purification steps. This innovation allows for production on an industrial scale, making it a valuable advancement in the field.
Career Highlights
Kirstein is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has focused on developing processes that enhance the efficiency and effectiveness of chemical synthesis. His contributions have been recognized within the industry, showcasing his expertise and innovative approach.
Collaborations
Holger Kirstein has collaborated with notable colleagues such as Johannes Platzek and Wolfgang Beckmann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Holger Kirstein's work in organic chemistry, particularly in the synthesis of benzocycloheptenes, highlights his innovative spirit and dedication to advancing pharmaceutical science. His contributions are paving the way for more efficient production methods in the industry.